Filter
233
Filtered Results: 233
Text search:
antiviral
prophylaxis
in
pregnancy
Featured
Recommendations
43
New Publications
90
Language
Document type
No document type
124
Guidelines
68
Studies & Reports
17
Manuals
11
Strategic & Response Plan
5
Training Material
3
Fact sheets
3
Situation Updates
1
Resource Platforms
1
Countries / Regions
India
10
South Africa
8
Kenya
7
Nepal
6
Nigeria
6
Asia
5
Latin America and the Carribbean
5
Western and Central Europe
4
Russia
4
Ethiopia
4
Zambia
4
Ukraine
3
Philippines
3
Global
3
Tanzania
3
Bangladesh
3
Uganda
3
Rwanda
2
Mozambique
2
Africa
2
Cambodia
2
Germany
2
South–East Asia Region
2
Vietnam
2
Eastern Europe
2
Myanmar / Burma
2
North Macedonia
1
Ghana
1
Sierra Leone
1
Albania
1
Laos
1
Malawi
1
Zimbabwe
1
Namibia
1
Georgia
1
South Sudan
1
Liberia
1
Eswatini/ Swaziland
1
Authors & Publishers
Publication Years
Category
Guidelines
25
Policies & Guidelines HIV & TB
24
COVID-19
15
Hepatitis
13
HIV & STI
13
Drugs & Medical Equipment
8
Pediatrics
7
Paediatrics
6
MPOX - Monkeypox
6
Studies & Reports
5
Policies
4
Capacity Building
4
Gynaecology & Obstetrics
4
Communicable Diseases
3
NCD
3
Respiratory Infections
3
General Guidelines
2
Vaccine-preventable Diseases
2
Hemorrhagic Fever
2
Clinical Guidelines
2
Surgery & Anaesthesia
2
Primary Health Care
2
Neonatal Care
2
Disease Prevention & Control
2
Clinical Training
1
Rabies
1
Pharmacy & Technology
1
Under-5 nutrition
1
Disaster Preparedness
1
Gender
1
Countries
1
Medical Devices & Equipment
1
Yellow Fever
1
Women & Child Health
1
Humanitarian Crisis
1
Waste Management
1
Immunization
1
Quality Control & Assurance
1
General Guidelines
1
Maternal Health
1
Pharmacy & Technologies
1
TB
1
Toolboxes
Clinical Guidelines
14
Country specific documents
13
Antiretroviral Treatment ART
11
Treatment Guidelines HIV
10
Reports & Studies
9
Clinical Aspects, Treatment & Prevention
7
Treatment & Prevention
6
Clinical Aspects
6
Essential Medicines & Devices Lists
6
Children & Adolescents
5
Treatment Guidelines
5
MPOX - Monkeypox
5
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
5
Asia and Pacific
5
Influenza Prevention & Control
4
Prevention Guidelines
4
HIV
4
HIV in Key Populations
4
Eastern Europe and central Asia
4
HIV testing & services
3
Surveillance
3
People who injecting Drugs
3
Research
3
Laboratory
3
Training, others
3
Co-Morbidities (except TB)
3
Research & Access
3
TB/HIV Coinfection
3
HIV service delivery
3
ART Drug Resistance
2
General Reports
2
Ebola Prevention & Control
2
Country specific
2
Surgery & Rehabilitation
2
Policies
2
Hepatitis
2
International
2
General
2
Essential List
2
Country Specific
2
Scientific & Research Studies
2
HIV and COVID-19
2
Oxygen Therapy
2
Essential Medicines & Medical Devices
2
TB/HIV
2
Midwives
2
Essential Medicines
2
Model Formulary
2
Pediatrics
2
Women & Maternal Health
2
General Guidelines for Rational Use
2
Health Care In Conflict Settings
2
MOPX - Monkeypox
2
Policies and guidelines
2
Education of students & professionals
2
Prevention of mother-to-child transmission (PMTCT)
2
HIV and coinfection
2
Testing Guidelines
2
Preparedness & Prevention
2
Clinical Guidelines
1
Policies & Strategies
1
Childhood TB
1
TB & Drug Abuse
1
IPC
1
Vaccines & Immunization
1
Yellow Fever
1
HIV surveillance
1
South Africa
1
Opportunistic Infections
1
Context, Facts & Travel Advice
1
Transgender People
1
Sexually Transmitted Infections
1
Eastern Europe
1
Others
1
TB
1
Hepatitis
1
Global
1
Prophylaxis
1
Vaccination
1
Ebola
1
Children
1
Human Rights
1
Sustainable Development Goals
1
Russia
1
IEC Substance Use Disorders
1
Climate & Health
1
Context & Facts
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
General
1
Context & Facts, Travel Advice
1
Clinical Aspects
1
Infection Control General
1
Diagnostics & Laboratory Guidance
1
Clinical Guidelines
1
Educational Settings
1
Paediatrics
1
COVID-19
1
Hospital Readiness/Essential Health Services
1
Blood Supply
1
Immunization Guidelines
1
Waste Management
1
Others
1
Advocacy & Communication
1
Rational use of Medicine
1
Traditional & Herbal Medicines
1
Surgery
1
Pharmaceutical Dosage Forms
1
Waste Managment
1
Situation Reports & Updates
1
Infectious Diseases
1
Health Impact & Climate Change
1
MPOX -Monkeybox Prevention & Control
1
Access to treatment and laboratory
1
General Information
1
Women
1
Neurological Disorders
1
Substance Use Disorders & Addiction
1
General Aspects
1
TB/HIV Global
1
Prophylactic Treatment
1
Technical Information
1
Stewardship
1
Latin America & the Carribean
1
HIV / AIDS
1
Zika Prevention & Control
1
Others
1
Western & Central Europe
1
Preparedness & Prevention
1
Laboratory & Diagnostics
1
Meningitis & Encephalitis
1
These guidelines have been extracted from the WHO manual Surgical Care at the District
Hospital (SCDH), which is a part of the WHO Integrated Management Package on Emergency
and Essential Surgical Care (IMPEESC).
Refer for details on anaesthesia, head, gunshot and landmine injuries in chapters
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention
Division of Tuberculosis Elimination
Accessed: 08.10.2019
This study aimed to understand the patterns of HIV drug resistance in pregnant women in Mozambique. This might help in tailoring optimal regimens for prevention of mother to child transmission of HIV (pMTCT) and antenatal care.
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...
• diagnosis of HIV
• update on the initiation of ART<...
Clinical guideline, Methods, Evidence and Recommendations
In this guideline the following is covered: information needs of people with chronic hep
titis B and their carers; where children, young people and adults with chronic hepatitis B a-
should be assessed; assessment of liver disease, includi...
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention.
Division of Tuberculosis Elimination.
Module 9
Strategic planning
July 2017
Module 9: Strategic planning. As WHO recommends offering PrEP to people at substantial HIV risk, this module offers public health guidance for policy-makers on how to prioritize services, in order to reach those who could benefit most from PrEP, and in wh...
Module 10
Testing providers
July 2017
Module 10: Testing providers. This module is for people who provide testing services at PrEP sites and laboratories. It offers guidance in selecting testing services, including screening of individuals before PrEP is initiated and monitoring while they ar...
In the time of coronavirus disease (COVID-19), sex and drug use will continue, regardless of physical distancing orders and policies. People who previously met in community gathering venues such as bars and clubs may now meet in different sites, ones that are “hidden” or less accessible. This, i...
WHO estimates that in 2015, 257 million people were living with chronic hepatitis B virus (HBV) infection worldwide, and that 900 000 died from HBV infection, mostly through the development of cirrhosis and hepatocellular carcinoma. Worldwide, the majority of persons with chronic hepatitis B infecti...
These guidelines provide evidence-based guidance on the use of peripartum antiviral prophylaxis in HBsAg-positive pregnant women for the prevention of mother-to-child transmission of HBV.
UNAIDS and the World Health Organization have published this updated guidance on ethical considerations in HIV prevention trials. The new guidance is the result of a year-long process that saw more than 80 experts and members of the public give inputs and is published 21 years after the first editio...
En estas directrices se actualiza la sección de recomendaciones sobre la prevención de la transmisión maternoinfantil de las Directrices para la prevención, la atención y el tratamiento de la infección crónica por el virus de la hepatitis B, publicadas por la OMS en el 2015, y se centra la at...
May 9, 2022.Since the onset of the COVID-19 pandemic, a large number of clinical trials have been planned and developed to assess the effectiveness and safety of various interventions that could prevent hospitalizations and progression to severe disease in people infected with SARS-CoV-2. Currently,...
Clinical features and management of human monkeypox: a retrospective observational study in the UK
recommended
Cases of human monkeypox are rarely seen outside of west and central Africa. There are few data regarding viral kinetics or the duration of viral shedding and no licensed treatments. Two oral drugs, brincidofovir and tecovirimat, have been approved for treatment of smallpox and have demonstrated eff...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate to severe disease, sexually active persons, pregnant or breastfeeding women, children and young persons...
